Holger Ulbrich

1.0k total citations
19 papers, 843 citations indexed

About

Holger Ulbrich is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Holger Ulbrich has authored 19 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Holger Ulbrich's work include Inflammatory mediators and NSAID effects (8 papers), Cell Adhesion Molecules Research (5 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Holger Ulbrich is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Cell Adhesion Molecules Research (5 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Holger Ulbrich collaborates with scholars based in Germany, Sweden and Australia. Holger Ulbrich's co-authors include Lennart Lindbom, Einar E. Eriksson, Gerd Dannhardt, Hermann J. Rothkötter, Reinhard Pabst, Oliver Soehnlein, Michael Scholz, Pierre Rotzius, Hans Flodgaard and Xun Xie and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and Trends in Pharmacological Sciences.

In The Last Decade

Holger Ulbrich

19 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger Ulbrich Germany 15 241 239 199 139 108 19 843
Hiroshi Azuma Japan 14 394 1.6× 377 1.6× 77 0.4× 111 0.8× 52 0.5× 40 1.2k
Anton Stuetz Austria 23 289 1.2× 328 1.4× 242 1.2× 64 0.5× 335 3.1× 35 1.5k
Nobuyuki Mizuno Japan 19 219 0.9× 136 0.6× 58 0.3× 121 0.9× 82 0.8× 80 908
Junsuke Arimitsu Japan 17 322 1.3× 229 1.0× 46 0.2× 102 0.7× 119 1.1× 32 1.1k
John Breton United States 17 360 1.5× 115 0.5× 234 1.2× 144 1.0× 18 0.2× 35 889
Laurie P. Shornick United States 16 324 1.3× 450 1.9× 62 0.3× 190 1.4× 76 0.7× 32 1.2k
A. I. Mallet United Kingdom 14 188 0.8× 198 0.8× 67 0.3× 116 0.8× 43 0.4× 31 644
Denis Thiolat France 16 332 1.4× 343 1.4× 336 1.7× 57 0.4× 19 0.2× 19 1.3k
Francesco Merlino Italy 21 508 2.1× 111 0.5× 88 0.4× 80 0.6× 48 0.4× 54 909
Víctor Ermilo Arana‐Argáez Mexico 13 494 2.0× 164 0.7× 59 0.3× 54 0.4× 48 0.4× 51 1.2k

Countries citing papers authored by Holger Ulbrich

Since Specialization
Citations

This map shows the geographic impact of Holger Ulbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Ulbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Ulbrich more than expected).

Fields of papers citing papers by Holger Ulbrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Ulbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Ulbrich. The network helps show where Holger Ulbrich may publish in the future.

Co-authorship network of co-authors of Holger Ulbrich

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Ulbrich. A scholar is included among the top collaborators of Holger Ulbrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Ulbrich. Holger Ulbrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pabst, Andreas, et al.. (2014). In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes. Clinical Oral Investigations. 19(1). 139–148. 35 indexed citations
2.
Sharma, Pawan K., Karan Singh, Pawan Kumar, et al.. (2010). Synthesis and anti-inflammatory evaluation of some pyrazolo[3,4-b]pyridines. Medicinal Chemistry Research. 20(2). 239–244. 35 indexed citations
3.
Scholz, Michael, et al.. (2008). Diaryl-dithiolanes and -isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, OH scavenging and anti-adhesive activities. Bioorganic & Medicinal Chemistry. 17(2). 558–568. 34 indexed citations
4.
Ulbrich, Holger, et al.. (2008). Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells. Biomarker Insights. 3. BMI.S692–BMI.S692. 14 indexed citations
5.
Scholz, Michael, et al.. (2008). Investigations Concerning the Correlation of COX‐1 Inhibitory and Hydroxyl Radical Scavenging Activity. Archiv der Pharmazie. 341(5). 281–287. 6 indexed citations
6.
Scholz, Michael, Holger Ulbrich, & Gerd Dannhardt. (2007). Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles. European Journal of Medicinal Chemistry. 43(6). 1152–1159. 29 indexed citations
7.
Ulbrich, Holger, Einar E. Eriksson, Oliver Soehnlein, et al.. (2006). A Novel Class of Potent Nonglycosidic and Nonpeptidic Pan-Selectin Inhibitors. Journal of Medicinal Chemistry. 49(20). 5988–5999. 22 indexed citations
8.
Soehnlein, Oliver, Alexander Schmeißer, Iwona Cicha, et al.. (2005). ACE Inhibition Lowers Angiotensin-II-Induced Monocyte Adhesion to HUVEC by Reduction of p65 Translocation and AT1 Expression. Journal of Vascular Research. 42(5). 399–407. 37 indexed citations
9.
Soehnlein, Oliver, Xun Xie, Holger Ulbrich, et al.. (2005). Neutrophil-Derived Heparin-Binding Protein (HBP/CAP37) Deposited on Endothelium Enhances Monocyte Arrest under Flow Conditions. The Journal of Immunology. 174(10). 6399–6405. 69 indexed citations
10.
Ulbrich, Holger, Oliver Soehnlein, Xuan Xie, et al.. (2005). Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow. Biochemical Pharmacology. 70(1). 30–36. 26 indexed citations
11.
Ulbrich, Holger, et al.. (2005). Characterization of a Computerized Assay for Rapid and Easy Determination of Leukocyte Adhesion to Endothelial Cells. Biological and Pharmaceutical Bulletin. 28(4). 718–724. 6 indexed citations
12.
Banwell, Martin G., Anna Bezos, Satish Chand, et al.. (2003). Convergent synthesis and preliminary biological evaluations of the stilbenolignan (±)-aiphanol and various congeners. Organic & Biomolecular Chemistry. 1(14). 2427–2429. 20 indexed citations
13.
Ulbrich, Holger, Einar E. Eriksson, & Lennart Lindbom. (2003). Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends in Pharmacological Sciences. 24(12). 640–647. 280 indexed citations
14.
Ulbrich, Holger, Bernd L. Fiebich, & Gerd Dannhardt. (2003). Cyclooxygenase‐1/2 (COX‐1/COX‐2) and 5‐Lipoxygenase (5‐LOX) Inhibitors of the 6,7‐Diaryl‐2,3‐1H‐dihydropyrrolizine Type.. ChemInform. 34(20). 1 indexed citations
15.
Ulbrich, Holger & Gerd Dannhardt. (2002). NSAR: Klassifizierung und Wirkspektrum: Eine heterogene Arzneistoffklasse. Pharmazie in unserer Zeit. 31(2). 146–154. 6 indexed citations
16.
Ulbrich, Holger. (2002). Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type. European Journal of Medicinal Chemistry. 37(12). 953–959. 58 indexed citations
17.
Stoyanova, Stefka, et al.. (2002). Inhibitory Activity of Tryptanthrin on Prostaglandin and Leukotriene Synthesis. Planta Medica. 68(10). 875–880. 59 indexed citations
18.
19.
Rothkötter, Hermann J., Holger Ulbrich, & Reinhard Pabst. (1991). The Postnatal Development of Gut Lamina Propria Lymphocytes: Number, Proliferation, and T and B Cell Subsets in Conventional and Germ-Free Pigs. Pediatric Research. 29(3). 237–242. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Azuma Breakdown of academic impact, for papers by Anton Stuetz Breakdown of academic impact, for papers by Nobuyuki Mizuno Breakdown of academic impact, for papers by Junsuke Arimitsu Breakdown of academic impact, for papers by John Breton Breakdown of academic impact, for papers by Laurie P. Shornick Breakdown of academic impact, for papers by A. I. Mallet Breakdown of academic impact, for papers by Denis Thiolat Breakdown of academic impact, for papers by Francesco Merlino Breakdown of academic impact, for papers by Víctor Ermilo Arana‐Argáez
Rankless by CCL
2026